Table 2.
Antibiotic susceptibility profile of isolates.
| Isolates | Antibiotics | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ampicillin (10 µg) | Vancomycin (30 µg) | Erythromycin (15 µg) | Azithromycin (15 µg) | Gentamycin (10 µg) | Penicillin (10 µg) | Chloramphenicol (30 µg) | Tetracycline (30 µg) | Streptomycin (10 µg) | Ciprofloxacin (5 µg) | |
| F1 | I | R | S | R | I | R | S | S | S | I |
| F2 | R | I | R | I | I | I | S | S | R | R |
| F3 | S | S | S | S | S | S | S | S | S | S |
| F4 | S | R | I | I | R | R | R | I | R | I |
| F5 | S | I | S | R | R | R | S | S | I | R |
| F6 | S | R | S | I | R | R | S | I | R | I |
| F7 | S | S | S | S | S | S | S | S | S | S |
| F8 | S | R | S | R | S | I | S | S | I | R |
| F9 | S | I | S | R | R | R | S | S | R | I |
| F10 | S | S | S | S | R | S | S | S | R | R |
| F11 | R | R | I | R | R | R | S | S | I | R |
| F12 | S | S | S | S | S | S | S | S | S | S |
| F13 | S | R | S | S | R | R | S | S | R | R |
| F14 | S | I | S | R | R | R | S | S | I | R |
| F15 | S | S | S | S | S | S | S | S | S | S |
| F16 | I | R | S | R | I | R | S | S | R | R |
| F17 | S | I | R | R | R | R | S | I | S | R |
| F18 | R | R | R | R | R | R | R | R | R | R |
| F19 | S | R | S | S | R | S | S | S | I | R |
I: intermediate susceptibility (zone diameter 12.5–17.4 mm); R: resistant (zone diameter < 12.4 mm); S: susceptible (zone diameter > 17.5).